Multiple Sclerosis Notes

my personal notes on multiple sclerosis scientific information

Thursday, September 24, 2020

Induction v escalation therapy in multiple sclerosis

›
Buron MD, Chalmer TA, Sellbjerg F.  Initial high-efficacy disease-modifying therapy in multiple sclerosis. A nationwide cohort study. Neurol...
Thursday, January 09, 2020

Canadian prednisone protocol oral for relapses

›
prednisone 50 mg Number 125 tablets Each day for five days, crush 25  tablets into powder, mix with orange soda take orally  
Thursday, December 05, 2019

Piriformis muscle exercises

›
https://www.summitmedicalgroup.com/library/adult_health/sma_piriformis_syndrome_exercises/
Wednesday, November 13, 2019

Optimum study Ponesimod v teriflunomide

›
Ponesimod won decisively in this phase 2 study in RRMS. 1333 patients were randomized. Ponesimod group had lower ARR,  by 30 percent;  less...

Onset of clinical and MRI efficacy of ocrelizumab in relapsing multiple sclerosis

›
Barkhof F, Kappos L, Wolinsky J.  Neurology; 2019; e1778-1786. Authors analyzed 163 individuals from partly blinded  phase II trials of o...
Thursday, May 02, 2019

European website for medicines

›
https://www.ema.europa.eu/en/medicines
Sunday, May 28, 2017

Bicams

›
https://www.bicams.net/

Symptom management in MS

›
Heat management 1.  cool pool 2,  Avoid hot showers 3. Hydration 4.  cooling vests and packs 5.  Lightweight clothes 6.  Rest a...

MS clinical resources that are commonly used

›
http://www.nationalmssociety.org/For-Professionals/Researchers/Resources-for-Researchers/Clinical-Study-Measures

Pearls on cognition in MS 2017 Consortium

›
1.  Ralph Benedict concluded that of all volume measurements the one that correlated best with cognitive deficits was third ventricle enlar...

Pearls on non MS demyelinating disease in kids

›
1.  CRION is rare in children is steroid dependent optic neuritis, relapse off steroids 2.  One presenter stated that ON + TM presentatio...

Pediatric MS pearls

›
1.  PPMS is very rare before age 18 2. associations include lots EBV, early menarche, obesity, HLA DR1*15 3. Kids with MS look genetica...

MS resources

›
SSD guide MS Society nationalMSsociety.org/SSDguide how to guide checklist of actions to take legal information *************** Pra...

Merry walker

›
Mary Harroun 21350 South Sylvan Drive Mendelein IL 60060 ph 847-837-9580 f     847-837-8582 www.merrywalker.com merrywalker@comcast...
Monday, October 26, 2015

fingolimod associated peripheral adverse effects

›
Russo M, Guarneri C, Mazzon E, et al.  Mayo Clin Proc 2015; 90(10)1424-7   prurplish acral lesion reappeared with rechallenge four y...
Wednesday, September 09, 2015

clemastine for MS

›
The   University of California, San Francisco   (UCSF) initiated a clinical trial to evaluate the antihistamine clemastine fumarate,...
Saturday, August 22, 2015

pacemakers and MRI

›
http://www.mypacemaker.com/mri-pacemakers/getting-a-pacemaker/index.htm?gclid=CjwKEAjwxMetBRDJx6Sz2p7DsQ0SJADJHAqNfosE_xSHoRpQbsztutw7...

Fwd: [MP4MS] MRI safe pacers

›
  = Basically there newer models of pacemakers that are MRI conditional given less use of ferromagnetic materials and more sophistic...
Friday, July 10, 2015

Fingolimod and LV dysfunction

›
   
Saturday, April 18, 2015

Daclizumab induced side effects

›
Oh J, Saidha S, Cortese I, et al.  Daclizumab induced side effects in multiple organ systems in multiple sclerosis. Neurology 2014; 82: ...
Wednesday, April 01, 2015

Fingolimod and MS: Four cautionary tales

›
editorial:  Bourdette D, Gilden D.  Neurology 2012; 79: 1942-3   This editorial goes with four case reports in same journal about ...
Saturday, March 28, 2015

pearls on vaccines in MS patients

›
1.  Standard guidelines indicate use of a killed and not inactivated vaccine v. influenzae is safe, but it should not be given during a ...

Imaging characteristics of NMO-SD esp in brain; update

›
Kim et al.  MRI characteristics of neuromyelitis optica spectrum disorder: an international update.Neurology 2015; 84: 1165-1173   W...

More on risk of PML Annals article

›
The only published data on indices that I am aware of, is in the Annals publication ("Anti–JC Virus Antibody Levels in Serum or Pla...
Friday, March 13, 2015

PLEX for central demyelination

›
Magana SM, Keegan M, Weinshenker BG, et al.,Beneficial plasma exchange response in central nervous sytem inflammatory demyelination.  Ar...
Sunday, March 08, 2015

Bowel regiment in MS

›
Bowel incontinence in MS occurs in two principal situations…(1) an augmented gastrocolic reflex (colonic motility with gastric diste...
Tuesday, December 02, 2014

Active v. progressive classification of MS

›
Lublin FD, Reingold SC, Cohen JA, et al.  Defining the clinical course of multiple sclerosis: the 2013 revisions.  Neurology 2014; 83:...
Thursday, November 13, 2014

Parent of origin effects in inherited MS

›
Herrera BM, Ramagopalan SV, Lincoln MR, et al.  Parent of origin effects in MS. Observations from avuncular pairs.  Neurology; 2008: 7...
Tuesday, November 04, 2014

Dalframpridine and trigeminal neuralgia

›
Birnbaum G., Iverson J.  Dalfampridine may activate latent trigeminal neuralgia in patients with multiple sclerosis.  Neurology 2014; 83: ...

Aubagio and birth defects

›
Annette M. Langer-Gould, Neurology 83; 2014:1685. response to a letter to editor. Teriflunamide is the active ingredient of leflunomid...
Monday, October 27, 2014

Fingolimod, and macular edema: pathophysiology, diagnosis and management

›
Cugati S. et al.  Neurology Clinical Practice, October, 2014 Review article Pearls 1. Mechanism is drug acts of S1P3 receptor as ago...
Wednesday, June 04, 2014

ADEM pearls

›
old paper, useful insights Menge T, Hemmer B, Nessler S et al  Acute disseminated encephalomyelitis: an update. Arch Neurol 2005; ...
Monday, June 02, 2014

Alochol protective against MS

›
Hedstrom AK, Hillert J, Olsson T et al.  Alcohol as a modifiable lifestyle factor affecting multiple sclerosis risk.  Jama Neurology 201...

antiMOG seronegative NMO

›
Kitley J, Waters P, Woodhall M, et al. Neuromyelitis optica spectrum disorders with aquaphorin-4 and Myelin-oligodendrocyte glycoprotein...

cog research tidbit on ms

›
Types of memory loss in ms Meta memory Cognitive fatigue Social emotional function   Mspt Rudick has iPad based testing ...

misc adverse effects tysabri and fingolimod

›
Tysabri Alopecia Dermatographia Bulbous pemphigoid Liver crisis Treatment withdrawal a Relapse on discontinuation Fingol...

adverse effects tysabri and fingolimod misc

›
Tysabri Alopecia Dermatographia Bulbous pemphigoid Liver crisis Treatment withdrawal a Relapse on discontinuation Fingol...

MS Consortium notes 2014 on pathology of MS

›
Miscellany Consortium 2014   MRI pearls   1)  T2 much better than flair in post fossa 2)  Black holes can resolve sometimes;...
Saturday, May 17, 2014

Fingolimod and atrial fibrillation

›
Rolf et al.  Paroxysmal atrial fibrillation after initiation of fingolimod for multiple sclerosis treatment   42 year old male had P...
Thursday, April 17, 2014

Fingolimod and birth defects

›
Karlsson G, Francis G, Koren G, et al. Pregnancy outcomes in the clinical development of fingolimod in multiple sclerosis.  Neurology 20...
Monday, January 06, 2014

anti MOG antibodies phenotype in adults

›
Joanna Kitley , BM, BS * ,  Mark Woodhall , PhD * ,  Patrick Waters , PhD * ,  M. Isabel Leite , DPhil ,  Emma Devenney , MB, Bch, Ba...
Saturday, August 10, 2013

EFrohman cocktail for reducing side effects of tecfidera

›
1. 0.5 to 1 mg of glycopyrrolate (Robinul) for GI 2. Baby ASA + 10mg of Zyrtec for flush, hot, etc.  Above taken 30-60 minutes b...
Thursday, July 04, 2013

Pearls on mitoxantrone related leukemia and toxicity

›
review article  Chan A and LoCoCo F.  MTX related acute leukemia in MS. An open or closed book> Neurology 2013; 80"1529-33. Pea...
Monday, June 17, 2013

Pearls Frohman's talk on symptom management AAN 2013

›
1.  70 % of MS patients have impaired sweating, or delayed sweating.  This complicates efforts to manage heat intolerance.   2. ...
Sunday, February 10, 2013

IRIS and Tysabri related PML

›
Tan IL, McArthur JC, Clifford DB, et al.  Immune reconstitution syndrome (IRIS) in natalizumab associated PML.  Neurology 2011; 77: 1061-1...
Friday, October 05, 2012

Two new studies on BG 12 a new oral for MS

›
Gold R et al. Define Investigators.  Placebo-controlled phase 3 study of oral BG12 for relapsing multiple sclerosis. NEJM 367:1098-1107 , 2...
Saturday, September 29, 2012

Signals for many immunosuppressant drugs and PML

›
Signals of progressive multifocal leukoencephalopathy for immunosuppressants: a disproportionality analysis of spontaneous reports wit...
Saturday, September 08, 2012

Interferon B for SPMS: a systematic review

›
La Mantia L, Vacchi L, Rovaris M et al.  JNNP 2012 Cochrane analysis of placebo controlled trials 1995-2012. 5 trials, 3082 patients. IFN...
Tuesday, September 04, 2012

Emerging therapies in MS AAN 2012 Mark Freedman

›
Random Notes   1.  Tereflunomide- blocks de novo synthesis of pyrimidine synthesis   "Nobody has a clue how these things re...

natalizumab Omar Khan AAN 2012 notes

›
These are random notes of interest   1  Natalizumab was originally used for MS relapses in the 1990s, published in Neurology; negati...
Sunday, September 02, 2012

MS notes AAN meeting Gilenya 2012

›
Jeffrey Cohen on Gilenya   1. O.5 mg daily is only approved dose, lower doses are being tested 2. May take a month or more to comple...
›
Home
View web version
Powered by Blogger.